TECHNOLOGY FIRMS ARE FINDING THEIR EXPERTISE ELSEWHERE
'HOLLOW' COMPANIES CONTRACT OUT TO CUT COSTS, STAY COMPETITIVE
Sandra Sugawara Washington Post Staff Writer
July 29, 1991; Page f1
An unwitting visitor to Cel-Sci Corp.'s Alexandria headquarters
might find things a bit baffling. The biotechnology company, which
hopes to use interleuken-2 to find a cure for cancer, doesn't own
a test tube or petri dish and has no research scientists on staff
A visit to the headquarters of TelePad Corp., which wants to sell
a hand-held computer that reads handwriting, would reveal that the
Reston company has no computer scientists and no manufacturing
facilities.
And a trip across the Potomac to the District headquarters of
Spacehab Inc., which is building a module for the space shuttle,
would show a company that has no in-house capability to design or
build anything to fly in space.
This absence of experts and expertise is by no means unique to
these three technology companies. The more common image of
technology firms might be companies with scores of white-coated
scientists or computer techies. In fact, only a handful of
Washington area commercial technology companies, such as software
firms Legent Corp. and American Management Systems Inc., have the
resources to offer most critical in-house services.
Others, such as Cel-Sci, are little more than hollow -- small
operations that draw up a strategy or game plan and raise the
financing, but are dependent on consultants, academic experts and
other companies to get the final product out.
These hollowed-out companies are by no means unique to Washington,
nor are they unique to the technology industry. But to understand
the Washington technology scene -- how these companies are able to
exist, what forces are determining the direction of their research
and what obstacles they face in trying to grow -- it is important
to understand that many of these companies are both more and less
than they seem.
For instance, Cel-Sci has only four full-time employees -- the
chairman, the chief financial officer and two secretaries. But
Geert R. Kersten, Cel-Sci's chief financial officer,
believes the term "employees" is meaningless these days.
"Employees are not what we call our people. We call them the
greater family of Cel-Sci, which includes the scientists,
consultants and advisers who have worked on this project over the
past eight years," said Kersten, who put the size of
the family at about 40.
Cel-Sci has contracted with scientists at the University of South
Florida to do its research. If that research results in a product,
Cel-Sci expects to hire an outside manufacturer to produce it, and
to form an alliance with another company to sell it. For other
functions needed to keep the company running -- bookkeepers,
accountants, lawyers, regulatory experts -- Cel-Sci depends on
outside experts or part-time staff.
Likewise Spacehab, which plans to lease a module to the National
Aeronautics and Space Administration that will expand the working
room on the space shuttle, has only eight employees. It hired
aerospace giant McDonnell Douglas Corp. to design the space module
and oversee the construction, and Italian aerospace company Alenia
SpA to build the outer shell.
By contracting out, the work could be performed at a fraction of
the time and cost it would have taken Spacehab if the company had
to assemble a team of experts and develop in-house manufacturing
capability.
In addition, while International Business Machines Corp. might be
able to pay the kind of money and provide the kind of research
budgets needed to lure the top technology brains out of academia,
few of the smaller technology companies can compete like that. The
consultant approach allows these companies to get access to such
scientists.
Thus Xsirius Superconductivity Inc., a Arlington company with 24
workers that is trying to develop commercial applications for
products using high-temperature superconductivity technology, is
able to hire leading experts from academia for annual consulting
fees of $20,000 to $30,000, said Charles M. Kupperman, president
of Xsirius
Superconductivity.
Other companies take other approaches. By trying to concentrate on
what it does best -- negotiating good prices for computer
equipment -- the ASC II Group Inc. in the District grew to a $2
billion operation in 1990. Instead of trying to build a computer
store chain from scratch by starting up its own stores or buying
out mom-and-pop operations, ASC II has assembled a group of 677
independently owned stores and charges them $250 a month to
negotiate volume rates for them.
"Five years ago, the religion was that you should be good in
everything. Now the realization is that the market is moving too
fast. You've got to know what your strengths are and then fill the
holes in," said Mike Farabelli, an Ernst & Young partner
who advises technology companies on acquisitions and strategic
alliances.
"You're going to see more of this in the future because of
globalization. Companies are realizing they can't be all things to
all people," Farabelli said.
"Maybe 15 years from now, the corporation as we know it will
not exist, the fully integrated enterprise offering all
services," said John Dealy, professor of business strategy at
Georgetown University's business school. "Instead the
corporation will be more a set of contracting relationships with a
core selling staff and core contracting staff."
Not everyone applauds the trend toward hollowing out. Jeffrey
Pfeffer, professor of organizational behavior at Stanford
University, warned that companies are taking an easy approach that
solves short-term problems and creates long-term ones.effectively,
Pfeffer said.
Executives acknowledge that they often have less control over work
that is done outside their corporate walls.
For instance, Kersten said Cel-Sci cannot dictate the pace
of the research when it is performed by academic scientists who
may be working on other projects or have teaching
responsibilities. Similarly, Cel-Sci cannot stop the scientists if
they want to publish something, such as findings that might not be
favorable to their product. Likewise, ASC II cannot control the
operation or policies of its stores, since it does not own them.
In addition, Wayne T. Hockmeyer, president of MedImmune Inc.,
warns that companies that depend too heavily on outsiders can be
bargaining away their future profits and growth.
MedImmune, a Gaithersburg biotech company, has taken a
middle-of-the-road approach to contracting out. For instance, some
research is done in-house and some at universities. Similarly,
MedImmune expects some sales to be handled by other companies and
some by an in-house sales staff.
Despite concerns about contracting out, Dealy predicted that more
companies will increasingly move toward performing only those
tasks for which they have a core competency and hire expertise
from others for remaining jobs.
"It's a more realistic approach to the way things are in the
world, which is rapidly changing," Dealy said. "If there
is a limited amount of capital resources around, why do we want to
be replicating institutions, rather than putting those resources
into product development and innovation?
Return
to CVM Knowledge Base